Nasdaq Markets

My family's portfolios are filled with internet retailers that are skyrocketing, Software-as-a-Service stocks that are soaring, and one vaccine biotech that has jumped 2,000%. It's my first year writing for The Motley Fool, and simultaneously the best year of my 20-year investing

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the equally impressive data from Moderna (NASDAQ: MRNA) about its candidate that takes a s

Retiring as soon as possible may seem like an attractive prospect if you're eager to spend your days on the golf course, spoiling your grandkids, or traveling the world. But while there are some benefits to quitting work when you're as young as possible, there are also some big a

Pfizer (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) reported incredible efficacy data from a phase 3 trial for their mRNA coronavirus vaccine candidate. This news, paired with the equally impressive data from Moderna (NASDAQ: MRNA) about its candidate that takes a s

After another quarter of selling off bank stocks, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) and its legendary chairman and CEO, Warren Buffett, are clearly getting more selective in the sector. As a result, there's a new pecking order among Berkshire's bank investments.By re

Many investors buy dividend stocks for one reason: They want a reliable income stream.Some stocks generate larger income streams, while others provide more reliability. If you're looking for both, check out these three dividend stocks.

Every month, Social Security doles out payments to nearly 65 million Americans, over 46 million of whom are retired workers. Without this guaranteed payout, more than 15 million retirees would be living below the federal poverty line.Ensuring the financial well-being of our natio

2020 has been a brutally volatile year for stocks. While the market is on track to finish solidly higher than it started on an incredible bounce back from the lows of late March, plenty of individual investors haven't enjoyed the same successes as the overall market. On the Oct.

This has been a trying year for Wall Street and the investment community. Though volatility is always present in the stock market, the swings we've witnessed this year are far beyond historical norms. For instance, the uncertainty caused by the coronavirus disease 2019 (COVID-19)

Saving for education can help minimize future student loan debt. Money you save now can grow and have huge benefits for your children down the road.In this video from the Motley Fool Live Financial Planning series, longtime contributor and Director of Investment Planning Dan Capl

(RTTNews) - The week ending November 20 saw some more good news on the COVID-19 front, with Pfizer (PFE) and German biotechnology company BioNTech (BNTX) making emergency use approval request to the FDA for their vaccine candidate on Friday. AstraZeneca PLC's (AZN) Covid-19 vacci

For investors looking for momentum, First Trust Nasdaq Artificial Intelligence and Robotics ETF ROBT is probably a suitable pick. The fund just hit a 52-week high and is up 96.8% from its 52-week low price of $22.51/share.

Moderna (NASDAQ: MRNA) recently announced an impressive efficacy of 94.5% from a late-stage study of coronavirus vaccine candidate mRNA-1273. The biotech stock jumped on the good news, but is it still a good pick to buy? That's the question that Healthcare and Cannabis Bureau Chi

2020 has seen a truckload of dividend cuts, suspended payouts, and unhappy shareholders, especially from high-profile companies like Disney and Ford. However, there are plenty of lesser-known companies that have increased their payouts to shareholders this year... and it's not to

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Ron Gross about the latest headlines and earning reports from Wall Street. They've got some updates on the coronavirus vaccines and talk about the cruise lines, the latest reports from some retail and hom

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) were the first drugmakers to announce interim efficacy results from a late-stage study of their coronavirus vaccine candidate. Moderna (NASDAQ: MRNA) had its turn last week. And -- like Pfizer and BioNTech -- the company had some ver

Fears about the future of Social Security have been around for decades, perpetuated in part by a general lack of understanding about how the program works. I'll be honest: Social Security isn't in a great spot, and 2020 has only thrown salt in its wounds.But the situation isn't q

In this video from Motley Fool Live recorded on Nov. 12, executives from Sorrento Therapeutics (NASDAQ: SRNE) talk about the company's second-generation therapeutic antibody. An investigational new drug (IND) application has been submitted to the Food and Drug Administration.Mark

This year has been pretty busy for IPOs despite the coronavirus pandemic. Online gaming platform Roblox has now officially filed its S-1 Registration Statement with the SEC after submitting a confidential filing last month. Like other video game companies, Roblox has seen a massi

Stocks ticked lower last week, as both the Dow Jones Industrial Average and the S&P 500 shed less than 1%. This left both indexes near their all-time highs and in positive territory so far in 2020.It's a shortened week ahead, but several big businesses will announce operating